eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2006, Volume 2, Issue 1 : 76-83 doi: ijmmas.2006.76.83
Research Article
Abnormal Myofibrillogenesis Potentiates Dystrophin Deficiency in Duchenne Muscular Dystrophy
Published
Dec. 30, 2005
Abstract

Myofiber hypertrophy occurs in Duchenne muscular dystrophy and appears to predispose specifically to necrosis of affected muscle cells.  Hypertrophy would constitute an abnormal response on the part of myofibers in muscular dystrophy that characterizes subsequent progression to necrosis.  Aberrant myofibrillogenesis would be implicated in such a process in a manner that would potentiate dystrophin deficiency as the individual myofibers undergo hypertrophy.   Abnormally induced gene transcription pathways would, in multiple ways, ultimately result in a complex setting that promotes sarcolemmal disruption.   Only in terms of such potentiation can one recognize a tendency for myofiber hypertrophy in the first instance and a subsequent evolution to individual myofiber necrosis.  Fibrosis develops as a series of injuries that are propagated by myofiber necrosis and loss, reflecting progressive and variable loss of dystrophin anchorage on sarcolemmae.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
Occupational Health Risks Among Healthcare Workers: Prevalence, Determinants, Clinical Consequences, and Prevention Strategies
1-4
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Professionalism and Ethics Education in Medical Schools: Assessing Knowledge, Attitudes, and Educational Outcomes Among Medical Students
16-20
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.